STOCK TITAN

Poet Technologies Inc SEC Filings

POET NASDAQ

Welcome to our dedicated page for Poet Technologies SEC filings (Ticker: POET), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

POET Technologies Inc. filings document a foreign private issuer developing optical engines, light sources and optical modules based on the POET Optical Interposer platform. Its Form 6-K reports furnish press releases on product development, customer order matters, partnerships, operating and financial results, and management discussion and analysis filed in Canada.

POET's regulatory record also covers capital structure and financing activity, including common-share offerings, shelf registration statements on Form F-3 and Form F-10, equity plan registration on Form S-8, shareholder voting matters, governance disclosures and material-event reports tied to commercialization, manufacturing scale-up and optical networking markets.

Rhea-AI Summary

MMCAP International Inc. SPC and MM Asset Management Inc. reported shared beneficial ownership of 19,047,620 common shares of POET Technologies Inc., representing 11.0% of the company's 172,595,406 shares outstanding as of May 18, 2026, following an offering by the issuer. The filing states the Fund holds the shares and the Adviser may be deemed to beneficially own them.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

POET TECHNOLOGIES INC. reports a Schedule 13G filing showing Marex affiliates beneficially own 9,150,000 shares of Common Stock, representing 6% of the class. The filing lists Marex Securities Products, Inc. and Marex Group plc with sole voting and dispositive power over those shares.

The filing includes CUSIP 73044W302 and identifies principal offices in New York and London. Signatures are dated 05/19/2026 and 05/06/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

POET Technologies Inc. closed a registered direct offering, issuing 19,047,620 common shares and a warrant for 19,047,620 additional shares to a single institutional investor for gross proceeds of US$400,000,020. Each unit was priced at US$21.00, above the prior NASDAQ close of US$20.57.

The three-year warrant carries an exercise price of US$26.25. POET plans to use the capital to expand manufacturing capacity, support acquisitions and partnerships, scale R&D and its light source business, grow global operations, and fund general working capital as it targets AI and data center interconnect markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.02%
Tags
current report
Rhea-AI Summary

POET Technologies Inc. has entered into a registered direct offering with a single institutional investor for 19,047,620 common shares and accompanying warrants for the same number of shares, at a combined price of US$21.00 per share-and-warrant unit, for aggregate gross proceeds of about US$400 million.

The net proceeds of roughly US$399.7 million are earmarked to expand manufacturing infrastructure, support corporate development and targeted acquisitions, scale research and development, accelerate the light source business, expand operations and provide general working capital. The units were priced at a premium to the prior NASDAQ closing price of US$20.57.

The warrants have a three-year term and are subject to a 9.99% beneficial ownership cap, limiting how much of the company the holder may control after exercises. Separately, the company recently appointed Sandeep Kumar as Chief Operating Officer, and long-serving CFO Thomas Mika has indicated plans to retire, prompting a search for his successor.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.02%
Tags
current report
-
Rhea-AI Summary

POET Technologies Inc. is offering 19,047,620 common shares and warrants to purchase up to 19,047,620 common shares as a unit, at a combined purchase price of $21.00 per share plus accompanying warrant. The warrants are exercisable at $26.25 per share, are immediately exercisable, subject to the Blocker Provision, and expire three years after issuance.

The offering is expected to deliver proceeds of approximately $400,000,020 (before expenses) and net proceeds of approximately $399,675,730, with delivery anticipated on or about May 18, 2026. Shares outstanding were 153,547,786 as of May 15, 2026, and the company projects 172,595,406 common shares outstanding immediately after this offering (assuming no warrant exercise).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.02%
Tags
prospectus
-
Rhea-AI Summary

POET Technologies Inc. reported first quarter 2026 revenue of $503,389, mainly from non-recurring engineering and product sales, as it continues commercializing its Optical Interposer-based photonic products for AI and hyperscale data centers.

The Company recorded a net loss of $12.3 million, or ($0.08) per share, compared with net income of $6.3 million a year earlier, largely due to lower non-cash gains on its derivative warrant liability and higher stock-based compensation. Cash used in operating activities was $8.8 million.

Strategically, POET announced a joint development and supply agreement with Lumilens that includes an initial $50 million purchase order for EOI-based optical engines and outlines a framework that could scale to more than $500 million in cumulative purchases over five years. The Company also advanced collaborations with LITEON and Lessengers on next-generation optical modules and a 1.6T transceiver platform, and plans to move its headquarters and domicile to the U.S., which is expected to eliminate potential PFIC classification in future years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.36%
Tags
current report
Rhea-AI Summary

POET Technologies Inc. entered a definitive agreement for a non-brokered registered direct offering, issuing 19,047,620 common shares and warrants for 19,047,620 additional shares at a combined price of US$21.00 per unit, for aggregate gross proceeds of US$400,000,020. The warrants carry an exercise price of US$26.15 per share and a three-year term. The price reflects a premium to the US$20.57 NASDAQ closing price on May 14, 2026. The company plans to use net proceeds to expand manufacturing infrastructure, support corporate development and targeted acquisitions, scale R&D, accelerate its light source business, expand operations, and for working capital. POET also highlighted leadership changes, including the recent appointment of Sandeep Kumar as Chief Operating Officer and the planned retirement in 2026 of longtime Chief Financial Officer Thomas Mika, with a search for his successor underway.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.36%
Tags
current report
-
Rhea-AI Summary

POET Technologies Inc. reports that MMCAP International Inc. SPC and MM Asset Management Inc. jointly beneficially own 14,516,820 Common Shares, representing 9.99% of the class as of the close of business on March 31, 2026. The position comprises 1,494,038 Common Shares and 13,022,782 Common Shares underlying warrants exercisable within 60 days. The filing uses a base share count of 132,290,739 Common Shares outstanding as of December 31, 2025.

The statement clarifies that the Fund directly owns the reported shares and that the Adviser may be deemed to beneficially own those shares as investment manager; each Reporting Person disclaims ownership of any shares other than those directly owned. Transactions or cash‑flow treatment are not described in the excerpt.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.36%
Tags
ownership
-
Rhea-AI Summary

POET Technologies Inc. reported a net loss of $12,344,086 for the three months ended March 31, 2026, compared with net income a year earlier. Revenue from non-recurring engineering and product sales rose to $503,389, showing early commercial activity but still far below operating costs.

Research and development expenses were $5,840,334 and selling, marketing and administration costs were $12,533,213, both heavily influenced by stock-based compensation. A fair value gain of $1,602,298 on the derivative warrant liability and interest income of $3,970,291 partly offset operating losses.

The balance sheet strengthened significantly, with total assets of $461,771,861 and cash, cash equivalents and short-term investments of $429,136,442 as of March 31, 2026, supported by substantial equity financings. Management highlights ongoing investment in 800G and 1.6T optical engines, AI-focused light sources, and Malaysian manufacturing expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.36%
Tags
current report
Rhea-AI Summary

POET Technologies entered a strategic supply and joint development partnership with Lumilens to create a new class of wafer-level photonic integration for next-generation AI optical networks, centered on an Electrical-Optical Interposer platform.

Under a supply agreement, Lumilens placed an initial purchase order with POET for EOI-based engines valued at $50 million, described as the first phase of a broader supplier relationship that could scale to $500+ million in cumulative purchases over five years. To align incentives, POET granted Lumilens a warrant to purchase up to 22,921,408 common shares at $8.25 per share over nine years, with 2,292,140 shares immediately exercisable and the remainder vesting as Lumilens makes additional payments under future purchase orders.

The roadmap targets 800G and 1.6T pluggable transceivers and next-generation Near-Package and Co-Packaged Optics, with engineering samples expected in late 2026 and a production ramp aligned to hyperscaler deployments in 2027. The companies note that revenue from these purchase orders depends on successful module development, qualification, and manufacturing scale-up, and POET highlights forward-looking risks around order realization, product performance, financing, and market acceptance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
43.15%
Tags
current report
-
Rhea-AI Summary

POET Technologies entered a strategic supply and joint development partnership with Lumilens to create a new class of wafer-level photonic integration for next-generation AI optical networks, centered on an Electrical-Optical Interposer platform.

Under a supply agreement, Lumilens placed an initial purchase order with POET for EOI-based engines valued at $50 million, described as the first phase of a broader supplier relationship that could scale to $500+ million in cumulative purchases over five years. To align incentives, POET granted Lumilens a warrant to purchase up to 22,921,408 common shares at $8.25 per share over nine years, with 2,292,140 shares immediately exercisable and the remainder vesting as Lumilens makes additional payments under future purchase orders.

The roadmap targets 800G and 1.6T pluggable transceivers and next-generation Near-Package and Co-Packaged Optics, with engineering samples expected in late 2026 and a production ramp aligned to hyperscaler deployments in 2027. The companies note that revenue from these purchase orders depends on successful module development, qualification, and manufacturing scale-up, and POET highlights forward-looking risks around order realization, product performance, financing, and market acceptance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.36%
Tags
current report

FAQ

How many Poet Technologies (POET) SEC filings are available on StockTitan?

StockTitan tracks 51 SEC filings for Poet Technologies (POET), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Poet Technologies (POET)?

The most recent SEC filing for Poet Technologies (POET) was filed on May 20, 2026.